NovaBridge Biosciences.
IMAB · NASDAQ
IMAB key statistics
- Market cap
- —
- Price-earnings ratio
- —
- Dividend yield
- —
- Average volume
- 923.59K
- Volume
- 615.09K
- Open price
- $1.30
- High today
- $1.46
- Low today
- $1.30
- 52 Week high
- $6.79
- 52 Week low
- $2.81
NovaBridge Biosciences. (IMAB) at a glance
NovaBridge Biosciences. (IMAB) last traded at $1.43.
Today the stock has traded between $1.30 and $1.46. The current price is 9.6% above the day's low and 2.4% below its high.
Volume so far is 615.09K shares, below the average of 923.59K shares a day.
Over the past year NovaBridge Biosciences. has ranged from $2.81 to $6.79, and now sits -35% of the way up that range.
The average analyst price target is $8.50, 496.5% above the current price, from 2 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy100.0%
- Hold0.0%
- Sell0.0%
- Low
- $7.07
- Now
- $1.43
- High
- $10.50
IMAB news
- Press releasePRNewswire
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of I-Mab - IMAB
- Press releasePRNewswire
Cellular Immunotherapy Breakthroughs Fuel $370 Billion Market Surge
- Press releasePRNewswire
Novel Cancer Platforms Converge as Clinical Data Reshapes Treatment Paradigms
12 Health Care Stocks Moving In Wednesday's Intraday Session
- Press releaseGlobe Newswire
I-Mab to Participate in September Investor Conferences
- Press releasePRNewswire
Everest Medicines Expands Strategic Investment in I-MAB
I-Mab to Join Virtual Biotech Event, Talks Cancer Treatment Progress With Investors
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.